Skip to content

The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer

The Effects of Whole Food Intervention on Mucositis in Patients Being Treated for Head and Neck Cancer With Radiation With or Without Chemotherapy

Status
Terminated
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02575313
Enrollment
10
Registered
2015-10-14
Start date
2009-10-31
Completion date
2012-09-30
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucositis

Keywords

L-Glutamine, chemotherapy, radiotherapy, therapeutic toxicity

Brief summary

This is a study to see if a Whole Food Intervention (WFI) consisting of yogurt, butter, honey, vanilla, and glutamine will lower the frequency or severity of mucositis in head and neck cancer patients undergoing standard treatment.

Detailed description

The proposal is a one center, open label, randomized pilot study to evaluate the safety, tolerability and compliance of a Whole Food Intervention with Standard of Care for patients with head & neck cancer. The primary objectives are: 1. To determine whether patients will use a Whole Food Intervention 4-6 times daily, and 2. To determine whether the Whole Food Intervention will reduce the incidence of grade 2 or greater mucositis from 75% historically seen to 25% . 3. To determine whether Whole Food Intervention will reduce the incidence of treatment breaks from \>19% to \< 10% (see section 9 for comments) This Whole Food Intervention will be taken by mouth before the start of radiation therapy, with or without chemotherapy and for the entire treatment therapy. Mucositis-related pain and reduction of oral intake will be quantified by using validated assessment tools. Weight loss or gain, diarrhea, constipation or no change in bowel function and the use of conventional medication for radiation-induced mucositis will be recorded. Chart review and patient questionnaires will be used to establish whether a treatment break or dose reduction for radiation of chemotherapy was required due to radiation mucositis-related symptoms. Complete Chemistry Profile and Complete Blood Count will be extracted from the patients' medical oncologist's or radiation oncologist's records. The patient will continue to use standard mucositis therapies if desired as prescribed by the treating oncology physician. The Whole Food Intervention consists of yogurt, butter, honey, vanilla, and glutamine with 3 portioning cups, equal to approximately 12 ounces, taken daily before starting radiation therapy. A questionnaire will be used to record symptoms and doses taken. The patient will continue to use standard mucositis therapies as prescribed by the treating oncology physician.

Interventions

DIETARY_SUPPLEMENTWhole Food Intervention

A combination of honey, glutamine, probiotics, and butter was administered to participants undergoing cancer.

Sponsors

Providence Health & Services
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Histopathologically confirmed diagnosis of head & neck carcinoma * Scheduled to undergo continuous daily course of radiation therapy with or without chemotherapy * No other serious concurrent medical illness as determined by the Principle Investigator * Absolute neutrophil count ≥ 500/mm3 * Platelet count ≥ 50,000/mm3 * No history of insulin-dependent diabetes mellitus * No prior hypersensitivity reaction to compound components

Exclusion criteria

* Dislike of the available forms of the WFI * Allergy or food intolerance relevant to the ingredients * Lack of access to refrigerated storage for the WFI * Inability or unwillingness to participate twice a week * Inability to swallow * Undergoing treatment for HIV with HIV medications * Ongoing alcohol and/or drug abuse

Design outcomes

Primary

MeasureTime frameDescription
Measurement of TolerabilityEight (8) weeksEstimated portion consumption on a daily basis was obtained to determine if the WFI could be tolerated by participants.

Secondary

MeasureTime frameDescription
Mucositis GradingEight (8) weeksMucositis grade was calculated using established criteria.
Treatment Break MeasurementEight (8) weeksTo determine whether Whole Food Intervention will reduce the incidence of treatment breaks from ≥19% to ≤10%.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026